Michael A. Klobuchar - 22 Jan 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP - Chief Strategy Officer
Signature
/s/ Kelly E. W. Grez, attorney-in-fact for Michael Klobuchar
Issuer symbol
MRK
Transactions as of
22 Jan 2024
Transactions value $
$465,299
Form type
4
Filing time
24 Jan 2024, 16:01:59 UTC
Previous filing
05 May 2023
Next filing
01 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Award $465K +3.9K +20.29% $119.43 23.1K 22 Jan 2024 Direct F1, F2
holding MRK Common Stock 6.29 22 Jan 2024 By Child
holding MRK Common Stock 6.29 22 Jan 2024 By Child
holding MRK Common Stock - 401(k) Plan 862 22 Jan 2024 By 401(k) F3
holding MRK Common Stock - 401(k) Plan 694 22 Jan 2024 By Spouse F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.
F2 Holdings include shares acquired in dividend reinvestment transactions.
F3 Includes shares acquired and dividends earned through January 8, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.